{
    "clinical_study": {
        "@rank": "28605", 
        "acronym": "RESC", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "Energetic Resonance by Cutaneous Stimulation", 
                "arm_group_type": "Experimental", 
                "description": "Energetic Resonance by Cutaneous Stimulation session in addition to standard treatment for patients with withdrawal alcohol symptoms."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of RESC study is to assess the efficacy of Energetic Resonance by Cutaneous\n      Stimulation on alcohol withdrawal symptoms measured by CUSHMAN score and in a second time to\n      measure the benzodiazepine amount prescribed during the withdrawal time."
        }, 
        "brief_title": "Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Alcohol Withdrawal Syndrome", 
        "condition_browse": {
            "mesh_term": "Substance Withdrawal Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women between 18 and 80 years,\n\n          -  Patient with alcohol addiction,\n\n          -  Patient needing alcohol withdrawal in a hospital.\n\n          -  Patient with social Security,\n\n          -  Patient with inform consent signed.\n\n        Exclusion Criteria:\n\n          -  Pregnant women\n\n          -  Minor.\n\n          -  Major with guardianship.\n\n          -  People without sufficient information because of troubles of cognitive functions, or\n             without sufficient knowledge of French language."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02146716", 
            "org_study_id": "2013-840"
        }, 
        "intervention": {
            "arm_group_label": "Energetic Resonance by Cutaneous Stimulation", 
            "description": "Energetic Resonance by Cutaneous Stimulation (RESC) is a non-invasive method based on energetic Chinese medicine principles and digital contact. RESC is characterized by echo phenomena between two stimulation points.", 
            "intervention_name": "Energetic Resonance by Cutaneous Stimulation", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "RESC, alcohol withdrawal syndrome", 
        "lastchanged_date": "May 21, 2014", 
        "location": {
            "contact": {
                "email": "claude.augustin-normand@chu-lyon.fr", 
                "last_name": "Claude Augustin-Normand, Dr", 
                "phone": "4.27.73.26.01", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Lyon", 
                    "country": "France"
                }, 
                "name": "H\u00f4pital croix rousse"
            }, 
            "investigator": {
                "last_name": "Claude Augustin-Normand, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.", 
        "overall_contact": {
            "email": "claude.augustin-normand@chu-lyon.fr", 
            "last_name": "Claude Augustin Normand, Dr", 
            "phone": "4.27.73.26.01", 
            "phone_ext": "+33"
        }, 
        "overall_contact_backup": {
            "email": "isabelle.delfour@chu-lyon.fr", 
            "last_name": "Isabelle Delfour", 
            "phone": "4.26.73.27.25", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "Hospices Civils de Lyon", 
            "last_name": "Claude Augustin-Normand, Dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "CUSHMAN score is represented by a scale with 7 variables collecting physiological modifications or behavioural manifestations related to adrenergic answer, neurovegetative signs, confusion, nervousness, perceptive or hallucinatory phenomena.", 
            "measure": "Cushman Score measure after Energetic Resonance by Cutaneous Stimulation", 
            "safety_issue": "No", 
            "time_frame": "daily during one week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02146716"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Anxiety depression scale", 
                "safety_issue": "Yes", 
                "time_frame": "pre-screening, day 3 and day 7"
            }, 
            {
                "measure": "prescribed benzodiazepine amount", 
                "safety_issue": "No", 
                "time_frame": "day 0 to day 7"
            }, 
            {
                "measure": "Analogic Visual Scale", 
                "safety_issue": "Yes", 
                "time_frame": "before and after each Energetic Resonance by Cutaneous Stimulationsession at day 2, day 4 and day 6."
            }, 
            {
                "measure": "Quality of life scale", 
                "safety_issue": "Yes", 
                "time_frame": "day 0"
            }
        ], 
        "source": "Hospices Civils de Lyon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospices Civils de Lyon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}